Depression in primary hyperparathyroidism: Prevalence and benefit of surgery

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 11, 2011, Pages

  Espiritu, Rachel P ^a   Kearns, Ann E ^a   Vickers, Kristin S ^a   Grant, Clive ^a   Ryu, Euijung ^a   Wermers, Robert A ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROIDECTOMY; PATIENT HEALTH QUESTIONNAIRE 9; POSTOPERATIVE PERIOD; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOTHERAPY; QUESTIONNAIRE; THYROID DISEASE; THYROID SURGERY; TREATMENT RESPONSE; UNITED STATES;

CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; DIAGNOSTIC SELF EVALUATION; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; PARATHYROIDECTOMY; PREVALENCE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 80655147280     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1486     Document Type: Article

References (40)

1. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, Melton 3rd LJ 2006 Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res 21:171-177 (Pubitemid 43023239)
2. Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR 2009 Presentation of asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop. J Clin Endocrinol Metab 94:351-365
3. Joborn C, Hetta J, Rastad J, Agren H, Akerström G, Ljunghall S 1988 Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism. Biol Psychiatry 23:149-158 (Pubitemid 18023092)
4. Chan AK, Duh QY, Katz MH, Siperstein AE, Clark OH 1995 Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study. Ann Surg 222:402-412; discussion 412-404
5. Wilhelm SM, Lee J, Prinz RA 2004 Major depression due to primary hyperparathyroidism: a frequent and correctable disorder. Am Surg 70:175-179; discussion 179-180
6. Joborn C, Hetta J, Lind L, Rastad J, Akerström G, Ljunghall S 1989 Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia. Surgery 105:72-78 (Pubitemid 19025086)
7. Pasieka JL, Parsons LL 1998 Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 22:513-518; discussion 518-519
8. Roman SA, Sosa JA, Mayes L, Desmond E, Boudourakis L, Lin R, Snyder PJ, Holt E, Udelsman R 2005 Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery 138:1121-1128; discussion 1128-1129
9. Solomon BL, Schaaf M, Smallridge RC 1994 Psychologic symptoms before and after parathyroid surgery. Am J Med 96:101-106 (Pubitemid 24070526)
10. Sywak MS, Knowlton ST, Pasieka JL, Parsons LL, Jones J 2002 Do the National Institutes of Health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism? Surgery 132:1013-1019; discussion 1019-1020
11. Chiang CY, Andrewes DG, Anderson D, Devere M, Schweitzer I, Zajac JD 2005 A controlled, prospective study of neuropsychological outcomes post parathyroidectomy in primary hyperparathyroid patients. Clin Endocrinol (Oxf) 62:99-104 (Pubitemid 40175290)
12. Dotzenrath CM, Kaetsch AK, Pfingsten H, Cupisti K, Weyerbrock N, Vossough A, Verde PE, Ohmann C 2006 Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism. World J Surg 30:680-685 (Pubitemid 43724094)
13. Walker MD, McMahon DJ, Inabnet WB, Lazar RM, Brown I, Vardy S, Cosman F, Silverberg SJ 2009 Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metab 94:1951-1958
14. Weber T, Keller M, Hense I, Pietsch A, Hinz U, Schilling T, Nawroth P, Klar E, Büchler MW 2007 Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism. World J Surg 31:1202-1209 (Pubitemid 47029908)
15. Benge JF, Perrier ND, Massman PJ, Meyers CA, Kayl AE, Wefel JS 2009 Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy. J Int Neuropsychol Soc 15:1002-1011
16. Bloom BS 2004 Prevalence and economic effects of depression. Manag Care 13:9-16
17. Whooley MA 2006 Depression and cardiovascular disease: healing the broken-hearted. JAMA 295:2874-2881 (Pubitemid 43974185)
18. Angst F, Stassen HH, Clayton PJ, Angst J 2002 Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 68:167-181 (Pubitemid 34628324)
19. Andersson P, Rydberg E, Willenheimer R 2004 Primary hyperparathyroidism and heart disease-a review. Eur Heart J 25:1776-1787 (Pubitemid 39330228)
20. Eskandari F, Martinez PE, Torvik S, Phillips TM, Sternberg EM, Mistry S, Ronsaville D, Wesley R, Toomey C, Sebring NG, Reynolds JC, Blackman MR, Calis KA, Gold PW, Cizza G 2007 Low bone mass in premenopausal women with depression. Arch Intern Med 167:2329-2336 (Pubitemid 350179528)
21. Pinto-Meza A, Serrano-Blanco A, Peñarrubia MT, Blanco E, Haro JM 2005 Assessing depression in primary care with the PHQ-9: can it be carried out over the telephone? J Gen Intern Med 20:738-742 (Pubitemid 41141006)
22. Littman AJ, White E, Satia JA, Bowen DJ, Kristal AR 2006 Reliability and validity of 2 single-item measures of psychosocial stress. Epidemiology 17:398-403 (Pubitemid 44305512)
23. Sloan JA, Aaronson N, Cappelleri JC, Fairclough DL, Varricchio C 2002 Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc 77:479-487 (Pubitemid 34465156)
24. Bilezikian JP, Potts Jr JT, Fuleihan Gel H, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells Jr SA 2002 Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 17(Suppl 2):N2-N11 (Pubitemid 35222306)
25. Kroenke K, Spitzer RL, Williams JB 2001 The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606-613 (Pubitemid 32823891)
26. Smolderen KG, Spertus JA, Reid KJ, Buchanan DM, Krumholz HM, Denollet J, Vaccarino V, Chan PS 2009 The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. Circulation 2:328-337
27. de Jonge P, Mangano D, Whooley MA 2007 Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Psychosom Med 69:735-739 (Pubitemid 350287480)
28. Löwe B, Unützer J, Callahan CM, Perkins AJ, Kroenke K 2004 Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care 42:1194-1201 (Pubitemid 39627296)
29. 2011 The Macarthur Initiative on Depression, Primary Care. Using the PHQ-9 to assess patient response to treatment. http://www.depression- primarycare.org/clinicians/toolkits/materials/forms/phq9/treatment-response/. Access date March 24, 2011
30. Brown GG, Preisman RC, Kleerekoper M 1987 Neurobehavioral symptoms in mild primary hyperparathyroidism: related to hypercalcemia but not improved by parathyroidectomy. Henry Ford Hosp Med J 35:211-215 (Pubitemid 18095661)
31. McAllion SJ, Paterson CR 1989 Psychiatric morbidity in primary hyperparathyroidism. Postgrad Med J 65:628-631 (Pubitemid 19223347)
32. Mjåland O, Normann E, Halvorsen E, Rynning S, Egeland T 2003 Regional cerebral blood flow in patients with primary hyperparathyroidism before and after successful parathyroidectomy. Br J Surg 90:732-737 (Pubitemid 36763588)
33. Perrier ND, Coker LH, Rorie KD, Burbank NS, Kirkland KA, Passmore LV, Tembreull T, Stump DA, Laurienti PJ 2006 Preliminary report: functional MRI of the brain may be the ideal tool for evaluating neuropsychologic and sleep complaints of patients with primary hyperparathyroidism. World J Surg 30:686-696
34. Linder J, Brimar K, Granberg PO, Wetterberg L, Werner S 1988 Characteristic changes in psychiatric symptoms, cortisol and melatonin but not prolactin in primary hyperparathyroidism. Acta Psychiatr Scand 78:32-40
35. Bollerslev J, Jansson S, Mollerup CL, Nordenström J, Lundgren E, Tørring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T 2007 Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92:1687-1692 (Pubitemid 46997172)
36. Quiros RM, Alef MJ, Wilhelm SM, Djuricin G, Loviscek K, Prinz RA 2003 Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 134:675-681; discussion 681-673
37. Coker LH, Rorie K, Cantley L, Kirkland K, Stump D, Burbank N, Tembreull T, Williamson J, Perrier N 2005 Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg 242:642-650 (Pubitemid 41567118)
38. Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C 2007 Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92:3114-3121 (Pubitemid 47236379)
39. Talpos GB, Bone 3rd HG, Kleerekoper M, Phillips ER, Alam M, Honasoge M, Divine GW, Rao DS 2000 Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathryoidism: patient description and effects on the SF-36 Health Survey. Surgery 128:1013-1020; discussion 1020-1021
40. Bilezikian JP, Khan AA, Potts Jr JT, Third International Workshop on the Management of Asymptomatic Primary Hypertension 2009 Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. J Clin Endocrinol Metab 94:335-339